Maternal Immunization

被引：101

作者：

Chu, Helen Y. ^{[1
]}

Englund, Janet A. ^{[2
]}

机构：

[1] Univ Washington, Dept Med, Div Allergy & Infect Dis, Washington, DC USA

[2] Seattle Childrens Hosp, Div Infect Dis, Dept Pediat, Washington, DC USA

来源：

CLINICAL INFECTIOUS DISEASES | 2014年 / 59卷 / 04期

基金：

美国国家卫生研究院;

关键词：

maternal immunization; influenza; tetanus; diphtheria; pertussis; INFLUENZAE TYPE-B; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; SYNCYTIAL VIRUS-INFECTION; PERTUSSIS TDAP IMMUNIZATION; PROTEIN CONJUGATE VACCINE; PREGNANT-WOMEN; ADVISORY-COMMITTEE; NEONATAL OUTCOMES; H1N1; INFLUENZA; PRACTICES ACIP;

D O I：

10.1093/cid/ciu327

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Maternal immunization has the potential to protect the pregnant woman, fetus, and infant from vaccine-preventable diseases. Maternal immunoglobulin G is actively transported across the placenta, providing passive immunity to the neonate and infant prior to the infant's ability to respond to vaccines. Currently inactivated influenza, tetanus toxoid, and acellular pertussis vaccines are recommended during pregnancy. Several other vaccines have been studied in pregnancy and found to be safe and immunogenic and to provide antibody to infants. These include pneumococcus, group B Streptococcus, Haemophilus influenzae type b, and meningococcus vaccines. Other vaccines in development for potential maternal immunization include respiratory syncytial virus, herpes simplex virus, and cytomegalovirus vaccines.

引用

页码：560 / 568

页数：9

共 73 条

[41]

Madhi S, 2014, 16 INT C INF DIS CAP

[42] Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants [J].

Madhi, Shabir A. ;

Dangor, Ziyaad ;

Heath, Paul T. ;

Schrag, Stephanie ;

Izu, Alaine ;

Sobanjo-ter Meulen, Ajoke ;

Dull, Peter M. .

VACCINE, 2013, 31 :D52-D57

[43] The price of prevention: what now for immunisation against meningococcus B? [J].

Moxon, Richard ;

Snape, Matthew D. .

LANCET, 2013, 382 (9890) :369-370

[44]

Mulholland K, 1996, JAMA-J AM MED ASSOC, V275, P1182, DOI 10.1001/jama.275.15.1182

[45] Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants A Randomized Clinical Trial [J].

Munoz, Flor M. ;

Bond, Nanette H. ;

Maccato, Maurizio ;

Pinell, Phillip ;

Hammill, Hunter A. ;

Swamy, Geeta K. ;

Walter, Emmanuel B. ;

Jackson, Lisa A. ;

Englund, Janet A. ;

Edwards, Morven S. ;

Healy, C. Mary ;

Petrie, Carey R. ;

Ferreira, Jennifer ;

Goll, Johannes B. ;

Baker, Carol J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (17) :1760-1769

[46] Group B Streptococcus vaccination in pregnancy: Moving toward a global maternal immunization program [J].

Munoz, Flor M. ;

Ferrieri, Patricia .

VACCINE, 2013, 31 :D46-D51

[47] Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women [J].

Munoz, FM ;

Piedra, PA ;

Glezen, WP .

VACCINE, 2003, 21 (24) :3465-3467

[48] Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation [J].

Munoz, FM ;

Englund, JA ;

Cheesman, CC ;

Maccato, ML ;

Pinell, PM ;

Nahm, MH ;

Mason, EO ;

Kozinetz, CA ;

Thompson, RA ;

Glezen, WP .

VACCINE, 2001, 20 (5-6) :826-837

[49] Vaccines in pregnancy [J].

Munoz, FM ;

Englund, JA .

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2001, 15 (01) :253-+

[50]

National Health Service, WHOOP COUGH VACC PRE

← 1 2 3 4 5 6 7 8 →